In conclusion, IGU ameliorates BLM-induced pulmonary inflammation in mice by blocking the TLR4/NFκB pathway, suppressing macrophage activation, and preventing M1 macrophage polarization, thereby reducing PF caused by the polarization of M2 macrophages and EMT in the advanced stage (Figure 9). This evidence concerns the gene NFKB1 and inflammatory response.